• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      June 2021 Volume 7 Issue 7

      May 2021 Volume 7 Issue 6

      Focus on Myeloid Malignancies (Volume 7, Issue 6.1)

      April 2021 Volume 7 Issue 5

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Christopher Flowers, MD

    Christopher Flowers, MD

    Department Chair, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
    • 2020 ASH Annual Meeting Preview: Conversations With Co-Chairs Monday, November 16th, 2020

      Education Program Co-chairs

    Sabrina Ahle
    Advertisement

    Current Issue

    June 2021 Volume 7 Issue 7

    Tuesday, June 1, 2021
    This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

    Block title

    R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit...

    Saturday, June 12, 2021

    Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML

    Saturday, June 12, 2021

    Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS

    Saturday, June 12, 2021

    Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

    Friday, June 11, 2021

    Fixed-Duration Ibrutinib, Venetoclax Oral Combination Effective in CLL/SLL

    Tuesday, June 8, 2021
    Recent Posts
    • R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit DLBCL
    • Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML
    • Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS
    • Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

    Meeting Coverage

    Researchers Validate Burkitt Lymphoma Prognostic Index

    Monday, March 1, 2021

    Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

    Monday, March 1, 2021

    Editor's Corner

    Editor’s Corner: It Takes a Village

    Tuesday, June 1, 2021

    Editor’s Corner: All Those YESterdays

    Saturday, May 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy